Literature DB >> 10348746

Molecular investigation of the postantibiotic effects of clarithromycin and erythromycin on Staphylococcus aureus cells.

W S Champney1, C L Tober.   

Abstract

The kinetics of recovery after inhibition of growth by erythromycin and clarithromycin were examined in Staphylococcus aureus cells. After inhibition for one mass doubling by 0.5 microg of the antibiotics/ml, a postantibiotic effect (PAE) of 3 and 4 h duration was observed for the two drugs before growth resumed. Cell viability was reduced by 25% with erythromycin and 45% with clarithromycin compared with control cells. Erythromycin and clarithromycin treatment reduced the number of 50S ribosomal subunits to 24 and 13% of the number found in untreated cells. 30S subunit formation was not affected. Ninety minutes was required for resynthesis to give the control level of 50S particles. Protein synthesis rates were diminished for up to 4 h after the removal of the macrolides. This continuing inhibition of translation was the result of prolonged binding of the antibiotics to the 50S subunit as measured by 14C-erythromycin binding to ribosomes in treated cells. The limiting factors in recovery from macrolide inhibition in these cells, reflected as a PAE, are the time required for the synthesis of new 50S subunits and the slow loss of the antibiotics from ribosomes in inhibited cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10348746      PMCID: PMC89272          DOI: 10.1128/AAC.43.6.1324

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  32 in total

1.  Simplified agar plate method for quantifying viable bacteria.

Authors:  B D Jett; K L Hatter; M M Huycke; M S Gilmore
Journal:  Biotechniques       Date:  1997-10       Impact factor: 1.993

2.  Growth kinetics of respiratory pathogens after short exposures to ampicillin and erythromycin in vitro.

Authors:  A U Gerber; W A Craig
Journal:  J Antimicrob Chemother       Date:  1981-11       Impact factor: 5.790

3.  Binding of novel macrolide structures to macrolides-lincosamides-streptogramin B-resistant ribosomes inhibits protein synthesis and bacterial growth.

Authors:  R C Goldman; S K Kadam
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

4.  Tight binding of clarithromycin, its 14-(R)-hydroxy metabolite, and erythromycin to Helicobacter pylori ribosomes.

Authors:  R C Goldman; D Zakula; R Flamm; J Beyer; J Capobianco
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

5.  A comparison of the inhibition of translation and 50S ribosomal subunit formation in Staphylococcus aureus cells by nine different macrolide antibiotics.

Authors:  W S Champney; C L Tober; R Burdine
Journal:  Curr Microbiol       Date:  1998-12       Impact factor: 2.188

6.  Correlation of tobramycin-induced inhibition of protein synthesis with postantibiotic effect in Escherichia coli.

Authors:  S Barmada; S Kohlhepp; J Leggett; R Dworkin; D Gilbert
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

Review 7.  Comparison of macrolide antibiotics.

Authors:  J D Williams; A M Sefton
Journal:  J Antimicrob Chemother       Date:  1993-03       Impact factor: 5.790

8.  Macrolide antibiotics inhibit 50S ribosomal subunit assembly in Bacillus subtilis and Staphylococcus aureus.

Authors:  W S Champney; R Burdine
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

9.  In-vitro activities of 14-, 15- and 16-membered macrolides against gram-positive cocci.

Authors:  J M Hamilton-Miller
Journal:  J Antimicrob Chemother       Date:  1992-02       Impact factor: 5.790

10.  Role of an energy-dependent efflux pump in plasmid pNE24-mediated resistance to 14- and 15-membered macrolides in Staphylococcus epidermidis.

Authors:  R C Goldman; J O Capobianco
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

View more
  4 in total

1.  Deletion of the multiple-drug efflux pump AcrAB in Escherichia coli prolongs the postantibiotic effect.

Authors:  William Stubbings; Julieanne Bostock; Eileen Ingham; Ian Chopra
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

2.  Time course of microbiologic outcome and gene expression in Candida albicans during and following in vitro and in vivo exposure to fluconazole.

Authors:  A Lepak; J Nett; L Lincoln; K Marchillo; D Andes
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

3.  Development of an extrachromosomal cloning vector system for use in Borrelia burgdorferi.

Authors:  M Sartakova; E Dobrikova; F C Cabello
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

4.  Impact of Target Turnover on the Translation of Drug-Target Residence Time to Time-Dependent Antibacterial Activity.

Authors:  Rajeswari Basu; Nan Wang; Sneha Basak; Fereidoon Daryaee; Mustufa Babar; Eleanor K Allen; Stephen G Walker; John D Haley; Peter J Tonge
Journal:  ACS Infect Dis       Date:  2021-08-06       Impact factor: 5.578

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.